A Phase Ib/II Trial of Ipilimumab-Nivolumab-Denosumab and Nivolumab-Denosumab in Patients with Unresectable Stage III and IV Melanoma (CHARLI Study).

  • Shackleton, Mark (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date10/12/20 → 31/12/22
View all
View less

Keywords

  • Medical oncology
  • Melanoma
  • Clinical trial